Inflammation, infection, and atherosclerosis

Brain, Behavior, and Immunity

Volumn 17, Issue 4, 2003, Pages 238-244

  Fahdi, Ibrahim E ^a   Gaddam, Venkat ^a   Garza, Luis ^a   Romeo, Francesco ^a   Mehta, Jawahar L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN;

ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; BACTERIAL INFECTION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; HEART INFARCTION; HUMAN; INFECTION; INFLAMMATION; LIPIDOSIS; MORBIDITY; MORTALITY; PARASITOSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS INFECTION;

EID: 0037709367     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(03)00052-7     Document Type: Article

References (66)

1. American Heart Association, American Stroke Association, 2002. Heart and Stroke Facts. American Heart Association.
2. Anderson J.L., Muhlestein J.B., Carlquist J.et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The azithromycin in coronary artery disease: Elimination of myocardial infection with Chlamydia (ACADEMIC) study. Circulation. 99:1999;1540-1547.
3. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes. 48:1999;1-9.
4. Boring L., Gosling J., Cleary M.et al. Decreased lesion formation in CCr2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897.
5. Buffon A., Biasucci L.M., Liuzzo G.et al. Widespread coronary inflammation in unstable angina. N. Engl. J. Med. 347:2002;5-12.
6. Chen L.Y., Haught W.H., Yang B.C.et al. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of anti-atherosclerotic effect of vitamin E, lovastatin and amlodipine. J. Am. Coll. Cardiol. 30:1997;569-575.
7. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet. 350:1997;430-436.
8. Danesh J., Peto R. Risk factors for coronary heart disease and infection with Heliobacter pylori: Meta-analysis of 18 studies. BMJ. 316:1998;1130-1132.
9. Dichtl W., Nilsson L., Goncalves I.et al. Very low-density lipoprotein activates nuclear factor-κB in endothelial cells. Circ. Res. 84:1999;1085-1094.
10. Ericson K., Saldeen T.G.P., Lindquis O.et al. Relationship of Chlamydia pneumoniae infection with severity of human coronary atherosclerosis. Circulation. 101:2000;2568-2571.
11. Fabricant C.G., Fabricant J., Litrenta M.M.et al. Virus-induced atherosclerosis. J. Exp. Med. 148:1978;335-340.
12. Fleming R.M. The effect of high protein diets on coronary blood flow. Angiology. 51:2000;817-826.
13. Frothingham C. The relation between acute infectious disease and arterial lesions. Arch. Intern. Med. 8:1911;153-162.
14. Fryer R.H., Schwobe E.P., Woods M.L.et al. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J. Invest. Med. 45:1997;168-174.
15. Fuster V., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J. Med. 32:1992;242-250.
16. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340:1999;448-454.
17. Gaydos C.A., Summersgill J.T., Sahney N.N.et al. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64:1996;1614-1620.
18. Geffken D.F., Cushman M., Burke G.L.et al. Association between physical activity and markers of inflammation in healthy elderly population. Am. J. Epidemiol. 153:2001;242-250.
19. Gu L., Okada Y., Clinton S.et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density-lipoprotein-deficient mice. Mol. Cell. 2:1998;275-281.
20. Gupta S., Leathanm E.W., Carrington D.et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 96:1997;404-407.
21. Gurfinkel E., Bozovich G., Beck E.et al. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndrome: The final report of the ROXIS study. Eur. Heart J. 20:1999;121-127.
22. Khoo J.C., Miller E., McLoughlin P.et al. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis. 8:1988;348-358.
23. Khoo J.C., Miller E., Pio F.et al. Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. Arterioscler. Thromb. 12:1992;1258-1266.
24. Kostis J.B., Turkevich D., Sharp J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am. J. Cardiol. 53:1984;997-999.
25. Kuller L.H., Tracy R.P., Shaten J.et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am. J. Epidemiol. 144:1996;537-547.
26. Kuo C.C., Grayston J.T., Campbell L.A.et al. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 year old). Proc. Natl. Acad. Sci. USA. 92:1995;6911-6914.
27. Kushner I., Sehgal A. Is high-sensitivity C-reactive protein an effective screening test for cardiovascular risk? Arch. Intern. Med. 162:2002;867-869.
28. Lawson D.L., Mehta J.L., Nichols W.W.et al. Superoxide radical-mediated endothelial injury and vasoconstriction of rat thoracic aortic rings. J. Lab. Clin. Med. 115:1990;541-548.
29. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995:1995;2844-2850.
30. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 105:2002;1135-1143.
31. Liuzzo G., Biasucci L.M., Gallimore J.R.et al. The prognostic value of C-reactive protein and serum amyloid A in sever unstable angina. N. Engl. J. Med. 331:1994;417-424.
32. Liuzzo G., Buffon A., Biasucci L.M.et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation. 98:1998;2370-2376.
33. Loebe M., Schuler S., Zais O.et al. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J. Heart Transpl. 9:1990;707-711.
34. Mattila K.J. Viral and bacterial infections in patients with acute myocardial infarction. J. Intern. Med. 225:1989;293-296.
35. Mattila K.J., Valle M.S., Nieminen M.S.et al. Dental infections and coronary atherosclerosis. Atherosclerosis. 103:1993;205-211.
36. Mayadas T.N., Johnson R.C., Rayburn H.et al. Leukocyte rolling and extravasation are severely compromised in P-selectin deficient mice. Cell. 74:1993;541-544.
37. Mehta J.L. Endothelium, coronary vasodilation, and organic nitrates. Am. Heart J. 129:1995;382-391.
38. Mehta J.L., Nicholas W.W., Mehta P. Neutrophils as potential participant in acute myocardial ischemia. J. Am. Coll. Cardiol. 11:1988;1309-1316.
39. Mehta J.L., Nicholas W.W., Donnelly W.H.et al. Protection by superoxide dismutase from myocardial dysfunction and attenuation of vasodilator reverse following coronary occlusion and reperfusion in dog. Circ. Res. 65:1989;1283-1295.
40. Melnick S.L., Shahar E., Folsom A.R.et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am. J. Med. 95:1993;499-504.
41. Morrow D.A., Rifai N., Antman E.M.et al. Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J. Am. Coll. Cardiol. 35:2000;358-362.
42. Neito F.J., Adam E., Sorlie P.et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation. 94:1996;922-927.
43. Peng H.B., Libby P., Liao J.K. Induction and stabilization of IκB autoregulatory by nitric oxide mediates inhibition of NF-κB. J. Biol. Chem. 270:1995;14214-14219.
44. Petrone W.F., English D.K., Wong K.et al. Free radicals and inflammation: Superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc. Natl. Acad. Sci. USA. 77:1980;1159-1163.
45. Phillips M.I., Kagiyama S., Chen H.J.et al. Angiotensin II as a mediator of inflammation in atherosclerosis. Mehta J.L. Inflammatory and Infectious Basis of Atherosclerosis. 2001;113-127 Birkhauser Verlag, Basel.
46. Price D.T., Loscalzo J. Cellular adhesion molecules and atherogenesis. Am. J. Med. 107:1999;85-97.
47. Rajavashisth T.B., Andalibi A., Territo M.C.et al. Induction of endothelial cell expression of granulocyte and macrophage colony stimulation factors by modified low-density lipoprotein. Nature. 344:1990;254-257.
48. Ramos C.L., Huo Y., Jung U.et al. Direct demonstration of P-selectin and VCAM-1 dependent mononuclear cell rolling in atherosclerotic lesions of apolipoprotein E-deficient mice. Circ. Res. 84:1999;1237-1244.
49. Ridker P.M., Cushman M., Stampfer M.J.et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336:1997;973-979.
50. Ridker P.M., Kundsin R.B., Stampfer M.J.et al. A prospective study of Chlamydia pneumonia IgG seropositivity and risks of future myocardial infarction. Circulation. 99:1999;1161-1164.
51. Ridker P.M., Hennekens C.H., Buring J.E.et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:2000;836-843.
52. Ridker P.M., Rifai N., Clearfield M.et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N. Engl. J. Med. 344:2001;1959-1965.
53. Romeo R., Martuscelli E., Chirieolo G.et al. Seropositivity against Chlamydia pneumoniae in patients with coronary atherosclerosis disease. Clin. Cardiol. 23:2000;327-330.
54. Ross R. The pathogenesis of atherosclerosis: A perspective for 1990s. Nature. 362:1993;801-809.
55. Ross R. Atherosclerosis: An inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
56. Rubanyi G.M., Ho E.H., Cantor E.H.et al. Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes. Biochem. Biophys. Res. Commun. 181:1991;1392-1397.
57. Rubanyi G.M., Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 250:1986;H822-H827.
58. Saikku P., Mattila K., Nieminen S.et al. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1:1988;983-985.
59. Schmidt A.M., Yan S.D., Wautier J.L.et al. Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. 84:1999;489-497.
60. Steinberg D., Witzum J.L. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted todate refute the hypothesis? Circulation. 105:2002;2107-2111.
61. Stone A.F., Mendall M.A., Kaski J.C.et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation. 106:2002;1219-1223.
62. Warnholtz A., Nickenig G., Schulz E.et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system. Circulation. 99:1999;2027-2033.
63. Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15:1995;551-561.
64. Woodhouse P.R., Khaw K.T., Plummer M.et al. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: Winter infections and death from cardiovascular disease. Lancet. 343:1994;435-439.
65. Wyrick P.B., Brunridge E.A. Growth of Chlamydia psittaci in macrophages. Infect Immun. 19:1978;1054-1060.
66. Yudkin J.S., Stehouwer C.D., Emeis J.J.et al. C-reactive protein in healthy subjects: Association with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19:1999;972-978.